Botanical species · safety record

Spatholobus suberectus

The EFSA Compendium of Botanicals holds 22 constituent measurements for Spatholobus suberectus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Spatholobus suberectus Dunn

22Constituent measurements
0Safety records
9Cited sources
147Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 147 licensed products naming Spatholobus suberectus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • decoction

Source material stated

  • Dried lianoid stem
  • New material
  • Root
  • Root and vine
  • Stem
  • Stem(s)
  • Vine
  • lianoid stem

What the records describe

Constituents measured

  • Isoflavones4
  • Proanthocyanidins (condensed tannins)2
  • Aloe-emodin1
  • Angelicin1
  • Calycosin1
  • Chrysophanol1
  • Daidzein1
  • Emodin1
  • Formononetin1
  • Furan derivatives1

Plant parts

  • Stem12
  • stalk12
  • Aerial part of plants10

Preparations

  • Solvent extraction22

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Aloe-emodinStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
CalycosinStem / stalkSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DaidzeinStem / stalkSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
EmodinAerial part of plantsSolvent extraction0.86 Milligram/gramCapillary (Zone) Electrophoresis (CE or CZE)Resolve DOI
FormononetinStem / stalkSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
GenisteinStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
IsoflavonesStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
IsoflavonesStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
IsoflavonesStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
MedicarpinStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
MedioresinolStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
PterocarpansStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
RheinAerial part of plantsSolvent extraction0.75 Milligram/gramCapillary (Zone) Electrophoresis (CE or CZE)Resolve DOI
AngelicinAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier
ChrysophanolAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier
Furan derivativesAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier
GallocatechinAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier
IsoflavonesStem / stalkSolvent extractionHPLC with standard detection methodsNo resolvable identifier
OnoninAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier
PhyscionAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier
Proanthocyanidins (condensed tannins)Aerial part of plantsSolvent extraction≤ 83.11 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
Proanthocyanidins (condensed tannins)Aerial part of plantsSolvent extraction≥ 29.74 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Zhang, Shuwei., Xuan, Lijiang. New phenolic constituents from the stems of Spatholobus suberectus. Helvetica chimica acta, 2006, vol. 89, no. 6, p. 1241-1245. DOI
  2. Yan, Qixin., Li, Ping., Wang, Di. Study on the liposoluble components of Caulis spatholobi. Zhongguo yaoke daxue xuebao, 2001, p. 336-338.
  3. Tang, Zhuxing., Zeng, Yikun., Zhou, Yun., He, Pingang., Fang, Yuzhi., Zang, Shuliang. Determination of active ingredients of spatholobus suberectus dunn and its medicinal preparations by capillary electrophoresis with electrochemical detection . Journal of liquid chromatography & related technologies, 2007, vol. 30, no. 1, p. 59-71. DOI
  4. Yoon, JS., Sung, SH., Park, JH., Kim, YC. Flavonoids from Spatholobus suberectus. ARCHIVES OF PHARMACAL RESEARCH, 2004, vol. 27, no. 6, p. 589-592. DOI
  5. Cheng, Y., Fu, Y., Wang, Z., Yang, D., Chen, J., Wang, D. Determination on the contents of condensed tannins in Spatholobus suberectus Dunn. extracts and primary study on their anti-tumor activities. Zhongshan daxue xuebao/acta scientiarum natralium universitatis sunyatseni, 2011, vol. 50, no. 2, p. 75-80.
  6. Lee, Mei-Hsien., Lin, Yi-Pei., Hsu, Feng-Lin., Zhan, Gui-Rong., Yen, Kun-Ying. Bioactive constituents of Spatholobus suberectus in regulating tyrosinase-related proteins and mRNA in HEMn cells. PHYTOCHEMISTRY, 2006, vol. 67, no. 12, p. 1262-1270. DOI
  7. Wang, D.-X., Liu, P., Chen, R.-Y., Chen, M.-L., Chen, G.-Y. Effect of monomers extracted from Spatholobus suberectus Dunn on proliferation of hematopoietic progenitor cells in marrow-depressed mice. Journal of clinical rehabilitative tissue engineering research, 2008, vol. 12, no. 21, p. 4163-4166.
  8. Tang Ren-Neng., Qu Xiao-Bo., Guan Shu-Hong., Xu Ping-Ping., Shi Yang-Yang., Guo De-An. Chemical constituents of Spatholobus suberectus. Chinese journal of natural medicines, 2012, vol. 10, no. 1, p. 32-35. DOI
  9. Lu, Dan., He, Hua., Wu, Bin., Yao, Shanjing. Cytotoxic effect on cancer cells and structural identification of phenols from Spatholobi caulis by HPLC-ESI-MSn. Natural product communications, 2009, p. 809-812.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue